Delivery Order SPE2DB22D2005-SPE2DB24FJPB4

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The award has a Firm Fixed Price of $10,168.56 and a completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $1,449.18, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract was awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support, which is part of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML syringes. The contract has a ceiling value of $7,777.66 and an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,912.32, has a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,089.62, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has a firm fixed price and an ultimate completion date of May 28, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The $3,375.96 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order worth $5,571.20 for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, with a ceiling value of $4,975.20 and a performance period through September 16, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,794.62, is for the delivery of the vaccine product PEDIARIX 0.5 ML SYRINGE 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,837.86 Firm Fixed Price Delivery Order is for the supply of the vaccine product PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has an Ultimate Completion Date of June 6, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJPB4
    Delivery Order

This is a Delivery Order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product, with a ceiling value of $18,508.43 and a period of performance through June 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/20/24, 9:23 AM